The global pain management devices market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.
Pain management devices aid in reducing chronic pain and other undesirable conditions. Pain management can be used as an alternative to surgery to improve the result of your medication. This allows a non-invasive platform for surgical procedures, which in turn will lead to an increase in the global market value. Recent technological advancements have opened up a huge pain management devices market growth potential.
Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/pain-management-devices-market-101069
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
-Medtronic
-Boston Scientific Corporation,
-LivaNova
-Abbott
-DJO Global LLC
-SPR Therapeutics
-Nevro Corp.
The report encompasses several factors that have contributed to the growth of the global pain management devices market. Besides this, the report includes a few of the factors that have acted as a barrier to market growth and signifies the market strategies adopted by leading companies, specifically aimed at overcoming these barriers.
The increasing number of people suffering from pain through chronic diseases will aid the growth of the global pain management devices market in the forthcoming years.
Get Sample PDF Brochure @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pain-management-devices-market-101069
According to the Centers for Disease Control and Prevention, around 20.4% of the total population in the US suffered from chronic pain in 2016. In addition to the increasing incidence of chronic pain, increasing neuropathic conditions will contribute to the increasing pain management devices market size.
“Launch of Technologically Advanced Pain Management Devices Likely to Enable Market Growth”
Technological advancements in pain management devices have played a huge part in the overall pain management market growth in recent years. Several companies have launched products with better feasibility and high operational efficacy.
In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy. The ‘Spectra WaveWriter SCS System’ was launched with the aim of offering a non-drug therapeutic approach for people suffering from chronic pain.
The report encompasses product launches, similar to Boston Scientific’s latest device and signifies the importance and impact of such devices on the global pain management devices market.
35% Rise in Regulatory Approvals for Pain Management Device Indicates a Huge Potential for Growth in the Foreseeable Future
Order Complete Report @ https://www.fortunebusinessinsights.com/checkout-page/101069
Segmentation:
By Application
• Musculoskeletal
• Brain
• Cancer
• Neuropathy
By End User
• Physiotherapy Centers
• Hospitals and Clinics
By Geography
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Rest of the World